Rx-Precision

Precision Medical Management

We improve outcomes and lower costs for high-risk, complex patient populations by personalizing their prescription plan to their DNA

The Problem

The Cost of Non-optimized Prescriptions

Most drugs that are currently available are “one size fits all,” but they don’t work the same way for everyone. It’s difficult to predict who will benefit from a medication, who will not respond at all, and who will experience negative side effects. This is especially true for high-cost, high-risk patients with complex chronic disease and polypharmacy.

5
These “non-optimized” medications result in an estimated $528 billion in annual healthcare costs and $200 billion in unnecessary and inappropriate prescription drug utilization1
5
Adverse drug reactions, often caused by non-optimized medications are the fourth leading cause of death and account for 7% of all hospital admissions and 20% of readmissions2, 3
5
Furthermore, many important classes of drugs are effective in only 25-60 percent of the patient population4

How Rx-Precision Works

The Rx-Precision Medical Management Platform

Through years of testing, design and application with health plan members, our Precision Medical Management platform has been carefully developed to duplicate the clinical improvements and cost savings in the most impactful precision medicine and genomic research. Our AI-driven precision medical analytics proactively identifies members who will clinically benefit from a genomic intervention and lead to lower costs and then guides the member and their physician through the entire testing and care plan optimization process. Our first solution is PGx-Guided Care.

Our PGx-Guided Care Targets the Costliest and Highest Risk Conditions

Oncology

Cardiovascular

Psychology

Autoimmune

Pain Management

Diabetes

Polypharmacy

Multi-morbidity

PGx-Guided Care™

A NEW PHARMACOGENOMICS CARE DELIVERY MODEL

Pharmacogenomics

Impact Analysis

Our proprietary technology leverages pharmacy, medical and eligibility claims data to identify the population that will clinically benefit from PGx testing and result in lower pharmacy and medical costs

Member Enrollment

Identified members receive education about the intervention via our certified enrollment specialists and are encouraged to participate in the program

Test Selection &

Case Management

Members opting-in are matched to the optimal PGx panel and supported through a clinical genomic case management process. Rx-Precision is PGx Lab agnostic, so we can select the most appropriate panel for each member

Member Counseling &

Physician Support

Each member is provided with genetic counseling and their physician is provided with a clinical action plan and peer-to-peer clinical decision support to implement recommended medication changes immediately

Outcomes Reporting

Payors receive comprehensive reports on member participation and satisfaction, post intervention drug-related morbidity and mortality reduction, pharmacy and medical spend reduction ROI. Employers also receive post-intervention data on absenteeism, presenteeism, productivity and stress reduction

Seamless Integration

We work with your existing team to add PGx-Guided Care to your existing strategy

Our PGx-Guided Care process is designed to integrate seamlessly with existing case management workflows and maximize the clinical and cost outcomes of complex, high-risk members. We understand being on the frontline of patient care and leverage our years of clinical experience in value-based settings to collaborate with the member’s care team.

Payor Benefits

agsdi-doctor

Precision Impact Analysis

Analyzes your entire member population to identify and predict which members will clinically benefit from PGx testing

agsdi-heartbeat

Improves Clinical Outcomes

Improves clinical outcomes for your high-risk, high-cost complex patients

agsdi-dollar

Lower Costs

Potentially lower pharmacy and medical costs for your highest-risk, complex patients

agsdi-flash

Improves Employee Productivity

Improved employee absenteeism, presenteeism and productivity

Billed as a Medical Claim

Because we contract with payors as a healthcare provider, PGx-Guided Care™ can be billed to your claims fund as a medical claim.

Let’s Get Started

Receive Your Complimentary Pharmacogenomics Impact Analysis for Your Member Population

Read More

For Payors

A turnkey pharmacogenomics risk management and medication optimization platform for employers, health plans, third-party administrators and other payors

The Study

Pharmacogenomic testing and case management for members with complex chronic disease.

The Science

Numerous clinical studies have documented that PGx testing leads to improved clinical outcomes and significant costs savings in the right patient populations.

1. Annals of Pharamcotherapy, 2018. Vol. 52(9) 829-837

2. Lazarou J, Pomeranz BH, Corey PN. JAMA . 1998 Apr 15;279(15):1200-5.

3. Foster, A.J., Murff, H.J., Peterson, J.F. et al. (2003). Ann Intern Med, 2003 Feb 4; 138(3).

4. Spear BB, Health-Chiozzi M, Hu J: Clinical Applications of Pharmacogenetics. Trends Mol. Med. 7, 201-204 (2001)

5. U.S. National Library of Medicine.

6. J. Med Econ. 2016;19(3): 213-28 Epub Nov 11, 2015.

7. Plos ONE 12(2): e0170905. https://doi.org10.1371/journal.pone.170905.

8. Sudia, Jason, “Exploring Barriers to the Adoption of Pharmacogenomic Technology in the Clinical Setting by Clinical Healthcare Providers” (2016) 138(3).

Resources

Privacy

Terms of Use

Copyright 2019 © Rx-Precision, Inc. All rights reserved.

Rx-Precision, Inc.
2945 Townsgate Rd.
Suite #200
Westlake Village, CA 91361

Rx-Precision

Precision Medical Management

We improve outcomes and lower costs for high-risk, complex patient populations by personalizing their prescription plan to their DNA

The Problem

The cost of non-optimized prescriptions. Most drugs that are currently available are “one size fits all,” but they don’t work the same way for everyone. It’s difficult to predict who will benefit from a medication, who will not respond at all, and who will experience negative side effects. This is especially true for high-cost, high-risk patients with complex chronic disease and polypharmacy.

C
These “non-optimized” medications result in an estimated $528 billion in annual healthcare costs and $200 billion in unnecessary and inappropriate prescription drug utilization1
C
Adverse drug reactions, often caused by non-optimized medications are the fourth leading cause of death and account for 7% of all hospital admissions and 20% of readmissions2, 3
C
Furthermore, many important classes of drugs are effective in only 25-60 percent of the patient population4

Our PGx-Guided Care Targets the Costliest and Highest Risk Conditions

Oncology

Pain

Management

Polypharmacy

Diabetes

Cardiovascular

Psychology

Autoimmune

Multi-morbidity

PGx-Guided Care™

Medication Impact Analysis

Our proprietary technology leverages pharmacy, medical and eligibility claims data to identify the population that will clinically benefit from PGx testing and result in lower pharmacy and medical costs

Member Enrollment

Identified members receive education about the intervention via our certified enrollment specialists and are encouraged to participate in the program

Test Selection & Case Management

Members opting-in are matched to the optimal PGx panel and supported through a clinical genomic case management process. Rx-Precision is PGx Lab agnostic, so we can select the most appropriate panel for each member

Member Counseling & Physician Support

Each member is provided with genetic counseling and their physician is provided with a clinical action plan and peer-to-peer clinical decision support to implement recommended medication changes immediately

Outcomes Reporting

Payors receive comprehensive reports on member participation and satisfaction, post intervention drug-related morbidity and mortality reduction, pharmacy and medical spend reduction ROI. Employers also receive post-intervention data on absenteeism, presenteeism, productivity and stress reduction

How it Works

Seamless Integration

We work with your existing team to add PGx-Guided Care to your existing strategy

Our PGx-Guided Care process is designed to integrate seamlessly with existing case management workflows and maximize the clinical and cost outcomes of complex, high-risk members. We understand being on the frontline of patient care and leverage our years of clinical experience in value-based settings to collaborate with the member’s care team.

Payor Benefits

agsdi-doctor

Precision Impact Analysis

Analyzes your entire member population to identify and predict which members will clinically benefit from PGx testing

agsdi-heartbeat

Improves Clinical Outcomes

Improves clinical outcomes for your high-risk, high-cost complex patients

agsdi-dollar

Lower Costs

Potentially lower pharmacy and medical costs for your highest-risk, complex patients

agsdi-people

Improves Employee Productivity

Improved employee absenteeism, presenteeism and productivity

Billed as a Medical Claim

Because we contract with payors as a healthcare provider, PGx-Guided Care™ can be billed to your claims fund as a medical claim.

Let’s Get Started

Receive Your Complimentary Pharmacogenomics Impact Analysis For Your Member Population

Read More

For Payors

A turnkey pharmacogenomics risk management and medication optimization platform for employers, health plans, third-party administrators and other payors

The Study

Pharmacogenomic testing and case management for members with complex chronic disease.

The Science

Numerous clinical studies have documented that PGx testing leads to improved clinical outcomes and significant costs savings in the right patient populations.

1. Annals of Pharamcotherapy, 2018. Vol. 52(9) 829-837

2. Lazarou J, Pomeranz BH, Corey PN. JAMA . 1998 Apr 15;279(15):1200-5.

3. Foster, A.J., Murff, H.J., Peterson, J.F. et al. (2003). Ann Intern Med, 2003 Feb 4; 138(3).

4. Spear BB, Health-Chiozzi M, Hu J: Clinical Applications of Pharmacogenetics. Trends Mol. Med. 7, 201-204 (2001)

5. U.S. National Library of Medicine.

6. J. Med Econ. 2016;19(3): 213-28 Epub Nov 11, 2015.

7. Plos ONE 12(2): e0170905. https://doi.org10.1371/journal.pone.170905.

8. Sudia, Jason, “Exploring Barriers to the Adoption of Pharmacogenomic Technology in the Clinical Setting by Clinical Healthcare Providers” (2016) 138(3).

Copyright 2019 © Rx-Precision, Inc. All rights reserved.

Rx-Precision, Inc.
2945 Townsgate Rd.
Suite #200
Westlake Village, CA 91361